Essential Pain Pharmacology (The Prescriber’s Guide)
- 作者Reza Tabrizchi PhD
- 卷第60卷
- 期第8期
- 文件大小163.18KB
- 发表时间2013-08
- DOI10.1007/s12630-013-9939-1
- 页码828-829
Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenograftsQing Chang; Mark S Chapman; Jeffrey N Miner; David W Hedley · 2010
An Orally Active Selective Androgen Receptor Modulator Is Efficacious on Bone, Muscle, and Sex Function with Reduced Impact on ProstateMiner, Jeffrey N.; Chang, William; Chapman, Mark S.; Finn, Patricia D.; Hong, Mei Hua; López, Francisco J.; Marschke, Keith B.; Rosen, Jon; Schrader, William; Turner, Russell; van Oeveren, Arjan; Viveros, Humberto; Zhi, Lin; Negro-Vilar, Andres · Endocrinology · 2007
Inhibitors of the anaplastic lymphoma kinaseMologni, Luca · Expert Opinion on Investigational Drugs · 2012
Melatonin in cardiovascular diseaseDominguez-Rodriguez, Alberto · Expert Opinion on Investigational Drugs · 2012
Drugs for bone healingBrandi, Maria Luisa · Expert Opinion on Investigational Drugs · 2012
Rheumatoid arthritis: developing pharmacological therapiesMoreland, Larry W; Misischia, Richard J · Expert Opinion on Investigational Drugs · 2002
New and investigational antiepileptic drugsStriano, Pasquale; Striano, Salvatore · Expert Opinion on Investigational Drugs · 2009
Ertapenem: a new carbapenemOdenholt, Inga · Expert Opinion on Investigational Drugs · 2001
Recent developments in carbapenemsNicoletti, Giuseppe; Russo, Giovanni; Bonfiglio, Giovanni · Expert Opinion on Investigational Drugs · 2002
The immunotherapeutic potential of melatoninMaestroni, Georges JM · Expert Opinion on Investigational Drugs · 2001